Kazakhstan vs Tonga: Cause of death, by non-communicable diseases, ages 5-14
Kazakhstan
38.6%
in 2021
Tonga
38.5%
in 2021
Kazakhstan rank
87th
Tonga rank
88th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Kazakhstan
- Tonga
How they compare
Kazakhstan currently reports 38.6% against 38.5% in Tonga, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kazakhstan ahead.
Kazakhstan ranks 87th and Tonga ranks 88th of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.1% | 33.0% | 0.1% | Kazakhstan |
| 2010s | 38.5% | 36.8% | 1.7% | Kazakhstan |
| 2020s | 39.9% | 38.3% | 1.5% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Kazakhstan or Tonga?
- Kazakhstan, at 38.6% against 38.5% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Kazakhstan and Tonga?
- 0.1%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Tonga rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Kazakhstan ranks 87th and Tonga ranks 88th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.